I-140 Immigrant Petition for Alien Worker (EB-2 National Interest Waiver) INTRODUCTION Dear USCIS Officer, This response is submitted in reply to the Request for Evidence (RFE) dated January 24, 2026, regarding my I-140 Immigrant Petition under the EB-2 National Interest Waiver (NIW) category. The RFE raised three primary issues: (1) whether my proposed endeavor Read More
Visit the URL and place your order with us. Fill basic details of your research paper, set the deadlines and submit the form.
Chat with our experts to get the best quote. Make the payment via online banking, debit/credit cards or through paypal. Recieve an order confirmation number.
Sit back and relax. Your well written, properly referenced research paper will be mailed to your inbox, before deadline. Download the paper. Revise and Submit.
I-140 Immigrant Petition for Alien Worker (EB-2 National Interest Waiver)
INTRODUCTION
Dear USCIS Officer,
This response is submitted in reply to the Request for Evidence (RFE) dated January 24, 2026, regarding my I-140 Immigrant Petition under the EB-2 National Interest Waiver (NIW) category. The RFE raised three primary issues: (1) whether my proposed endeavor has national importance; (2) whether I am well positioned to advance the proposed endeavor; and (3) whether, on balance, it would be beneficial to the United States to waive the job offer and labor certification requirements.
I respectfully submit that the evidence provided in this response fully addresses each of these concerns. The RFE expressed concern that my proposed endeavor, as originally described, might be limited to individual clinical practice. In this response, I provide substantial additional detail and clarification regarding the true scope and nature of my work. The proposed endeavor has not changed; rather, the significant body of evidence supporting its national importance, scalability, and system-level impact has been further developed and is now presented in greater detail. What was previously summarized is now comprehensively documented with validated results from prior implementation, integration with national research infrastructure, and a clear three-year implementation plan with dedicated funding.
The evidence demonstrates that my endeavor is not about adding a single electrophysiology cardiologist to the U.S. workforce. Rather, it is a comprehensive, scalable system-level intervention designed to transform arrhythmia care delivery across the United States by improving early symptom recognition, enhancing physician diagnostic capacity, and establishing efficient referral pathways. This distinction is fundamental to understanding why this endeavor warrants a national interest waiver independent of the labor certification process.
PART ONE: CLARIFICATION — THE PROPOSED ENDEAVOR IS A SYSTEM-LEVEL INTERVENTION, NOT A CLINICAL ROLE
The RFE noted that my proposed endeavor, as originally described, might be limited to individual clinical practice and that shortages of qualified workers are addressed through the labor certification process. I wish to clarify that my proposed endeavor has not changed. Rather, the initial filing necessarily provided a summarized description of a complex, multifaceted initiative. This response provides the detailed elaboration that the RFE appropriately requests, demonstrating that my work is fundamentally a system-level intervention designed to improve healthcare delivery across multiple institutions and populations.
My goal is not to fill a specific employment position. I am not seeking to become “an electrophysiology cardiologist” in the United States in the traditional sense of assuming a patient-facing clinical role within a single institution. Rather, I bring the full expertise of an electrophysiology cardiologist—including clinical knowledge, procedural training experience, and simulation-based education infrastructure—as the foundation upon which I will build a system-level intervention. In this endeavor, my clinical identity is the means, not the end. The end is a scalable, sustainable arrhythmia care network that will continue to function and improve outcomes long after the initial implementation phase.
The value of my endeavor lies not in the clinical services I would personally provide, but in the system I would build, the physicians I would train (through partnership with U.S. institutions), and the care pathways I would establish that would continue to function and improve outcomes long after the initial implementation.
A traditional employment-based role is defined by a specific job description, a single employer, and individual clinical responsibilities. My proposed endeavor shares none of these characteristics. To be clear: while I am an electrophysiology cardiologist by training and expertise, I am not seeking to practice as one in the traditional, patient-facing sense. Instead, I am leveraging that expertise—combined with my experience in system-level implementation, educational content development, and simulation-based training—to build an infrastructure that multiplies the effectiveness of the existing U.S. electrophysiology workforce.
Not tied to a single employer: The model operates across multiple institutions, including tertiary electrophysiology centers (Emory University Hospital Midtown, Piedmont Atlanta Hospital), specialist centers (Northside Hospital Atlanta, WellStar Kennestone Regional Medical Center, Emory Decatur Hospital, Piedmont Fayette Hospital), regional cardiology institutions (WellStar Douglas Medical Center, Southern Regional Medical Center, Piedmont Henry Hospital, Piedmont Rockdale Hospital), and all 18 Georgia Public Health District Offices (Rome, Dalton, Gainesville, Marietta, Atlanta, Jonesboro, Lawrenceville, Decatur, LaGrange, Dublin, Macon, Augusta, Columbus, Valdosta, Albany, Savannah, Waycross, and Athens). No single employer can claim ownership of this initiative.
Not defined by a job description: The work encompasses patient education program development, physician training curriculum design, referral pathway standardization, public health engagement, data infrastructure development (including Natural Language Processing algorithms within PCORnet), and continuous quality improvement. These activities span domains that no single job description could encompass.
Not measured by individual clinical volume: The success of this endeavor will be measured by population-level outcomes: reductions in diagnostic delay across Georgia, increases in appropriate anticoagulation rates, decreases in referral times, and reductions in adverse cardiovascular events. These are system performance metrics, not individual productivity metrics.
The RFE correctly notes that workforce shortages are addressed through the labor certification process. My proposed endeavor, however, addresses a different problem: not the absence of electrophysiology cardiologists, but the inefficient utilization of existing healthcare resources.
The U.S. healthcare system already possesses advanced electrophysiology capabilities in major metropolitan centers. The problem is that patients in rural and underserved communities cannot access these capabilities in a timely manner because of fragmented referral pathways, insufficient frontline physician training, and low patient awareness. Adding one more electrophysiology cardiologist to an urban center does not solve this problem. Improving how the entire system functions does.
My model achieves workforce optimization through three mechanisms:
This is workforce optimization, not workforce expansion. It enhances the effectiveness of the existing U.S. healthcare workforce without adding new positions that would compete with U.S. workers.
PART TWO: THE PROPOSED ENDEAVOR — A MULTILEVEL ARRHYTHMIA AWARENESS, PHYSICIAN EDUCATION, AND REFERRAL COORDINATION NETWORK
The proposed endeavor is the development and implementation of a multilevel cardiovascular awareness, physician education, and referral coordination network focused on cardiac arrhythmias, particularly atrial fibrillation and related rhythm disorders that frequently lead to serious complications when not recognized and managed in a timely manner. This initiative is not a traditional clinical role within a single institution; it represents a structured, system-level intervention designed to improve the performance of the entire arrhythmia care pathway within the United States healthcare system.
The project addresses a critical and well-documented gap in healthcare delivery: the disconnect between early symptom onset, frontline clinical recognition, and timely referral to advanced electrophysiology services. Many patients fail to recognize symptoms such as palpitations, irregular heartbeat, dizziness, or syncope as indicators requiring medical evaluation, while frontline physicians encounter practical challenges in identifying which patients require specialist referral. As a result, diagnosis is frequently delayed, treatment initiation is inconsistent, and access to definitive care is inefficient, even in regions where advanced medical infrastructure is available.
To address this structural inefficiency, the proposed endeavor establishes a coordinated, multilevel system integrating public health infrastructure with clinical care delivery. At the population level, Public Health District Offices function as entry points for community-based screening, patient education, and early risk identification. At the clinical level, the model introduces a tiered referral structure in which community-level access points serve as the first contact layer, followed by regional cardiology centers responsible for diagnosis and initial management, specialist electrophysiology centers that provide intermediate triage and coordination, and tertiary electrophysiology hubs that deliver advanced interventions such as catheter ablation.
This model is designed to ensure timely patient progression through the care pathway, reduce delays in diagnosis and treatment, and optimize the use of existing healthcare resources. Importantly, the proposed initiative does not require the creation of new infrastructure; instead, it systematically integrates already established institutions into a coordinated and efficient network through education, structured referral pathways, and system-level organization.
The implementation strategy is structured and phased. The initial phase will be conducted in the Atlanta metropolitan region, where a high concentration of advanced electrophysiology centers coexists with a large and diverse patient population and a fragmented referral structure. This setting provides an ideal environment to demonstrate immediate feasibility within an existing healthcare system. Following successful implementation, the model will be expanded across the State of Georgia, incorporating both urban and rural healthcare settings and leveraging the statewide Public Health District system to ensure broad population coverage.
The proposed endeavor is grounded in a previously developed and implemented multilevel model that demonstrated measurable improvements in clinical and operational outcomes, including reductions in diagnostic delay, improved referral efficiency, increased adherence to guideline-based therapy, and a significant reduction in adverse cardiovascular events. These findings provide a validated foundation for the proposed U.S. implementation and support its feasibility and expected impact.
In addition to improving clinical outcomes, the model is expected to generate substantial economic benefits by reducing preventable complications such as stroke, decreasing hospitalizations and emergency care utilization, and enabling earlier and more cost-effective intervention. These gains are achieved through improved system efficiency rather than increased resource consumption, resulting in a highly cost-effective and scalable approach to healthcare delivery improvement.
First, patient-level awareness. Educational materials and structured programming will be developed to help individuals recognize early symptoms such as palpitations, irregular pulse, dizziness, syncope, and unexplained fatigue as potential indicators of underlying arrhythmia. I have already developed a comprehensive patient education booklet titled “Atrial Fibrillation: Patient Information Booklet,” which has been published by the University of Health Sciences and is currently used in clinical practice. This material, available in both Turkish and English, provides structured guidance on symptom recognition, treatment options, medication adherence, and lifestyle modifications. This existing resource will serve as the foundation for the patient education component of the U.S. initiative, with adaptation for cultural and linguistic appropriateness across diverse American communities.
Importantly, this patient education effort will be informed by and integrated with existing community-based initiatives. The National Heart, Lung, and Blood Institute’s Community Engagement Alliance (CEAL) works with nearly 1,200 community-based organizations to conduct formative research in local clinics and rural communities. My initiative will align with and complement these existing efforts, ensuring that arrhythmia-specific education is integrated into broader cardiovascular health promotion activities.
A Critical Distinction: Patient Education vs. Physician Education
It is important to distinguish between the two educational components of my proposed endeavor, as they operate under different regulatory frameworks in the United States.
Patient education—including the development of informational materials, community-based seminars, and digital content—does not require U.S. medical licensure. I have already developed and published evidence-based patient education materials. These can be adapted for U.S. audiences and disseminated through:
This component can begin immediately upon approval of this petition and will generate measurable impact in the form of improved patient awareness, earlier care-seeking behavior, and increased treatment adherence.
Physician education, by contrast, involves training U.S. physicians in advanced techniques and will be implemented through partnership with U.S. academic institutions. I will not function as an independent educator. Rather, I will contribute my simulation infrastructure and educational expertise to partner institutions that possess the legal authority, accreditation, and infrastructure to deliver continuing medical education. This distinction is elaborated in Part Twelve.
Second, physician education. This component targets first-contact providers and non-electrophysiology clinicians, including primary care physicians, internists, general practitioners, and general cardiologists. The education focuses on early arrhythmia suspicion, interpretation of common electrocardiographic patterns, identification of high-risk clinical presentations, and appropriate timing for referral to cardiology or electrophysiology services.
I have extensive experience in this area, having trained dozens of cardiology fellows and practicing physicians in Turkey. Additionally, my center at the University of Health Sciences has been recognized as an EHRA Recognized Training Centre since February 2023, a distinction awarded by the European Heart Rhythm Association that acknowledges excellence in electrophysiology education and training. This recognition validates my capacity to develop and deliver high-quality physician training content.
However, I recognize that providing physician education in the United States requires institutional sponsorship, accreditation, and appropriate credentialing. Therefore, I will implement this component through strategic partnerships with U.S. academic institutions. My role will be to:
This partnership-based approach ensures that all educational activities are conducted within the established U.S. regulatory framework by appropriately credentialed U.S. faculty, while still leveraging my unique expertise and tangible assets.
Third, standardized referral coordination. The model introduces a structured referral logic that defines how patients move through the healthcare system once an arrhythmia is suspected or identified. Rather than relying on informal or inconsistent referral practices, the model introduces a structured pathway linking community-level access points, regional cardiology centers, specialist electrophysiology services, and tertiary intervention centers. Community-level access points serve as the first clinical interface, followed by regional cardiology centers responsible for electrocardiographic confirmation, initiation of guideline-directed therapy, and identification of patients requiring advanced intervention. Specialist electrophysiology centers function as intermediate triage nodes, providing diagnostic refinement and coordinating referrals, while tertiary electrophysiology hubs—such as Emory University Hospital Midtown and Piedmont Atlanta Hospital—serve as definitive treatment centers for advanced procedures, including catheter ablation.
This structured escalation pathway—extending from Public Health District-based entry points through community access, regional cardiology centers, specialist electrophysiology centers, and ultimately tertiary hubs—ensures timely patient progression, reduces delays in diagnosis and treatment, and optimizes the utilization of existing healthcare resources. The model does not require the creation of new infrastructure; rather, it systematically integrates already established institutions into a coordinated, efficient, and scalable network.
This model is not theoretical. I previously developed and implemented a structurally similar multilevel arrhythmia care model in Turkey, which was evaluated through a structured interventional study involving 11 rural healthcare facilities, 524 patients, and 31 rural physicians. The results, which are currently under review for publication in the Anatolian Journal of Cardiology, demonstrate significant and measurable improvements:
| Clinical Parameter | Pre-Program | Post-Program | Change |
| Time to diagnosis (weeks) | 14.5 ± 6.2 | 5.2 ± 2.8 | 64% reduction (p < 0.001) |
| Appropriate anticoagulation use | 42% | 79% | 88% increase (p < 0.001) |
| Referral time to ablation (months) | 11.3 ± 4.5 | 4.1 ± 2.1 | 64% reduction (p < 0.01) |
| Physician ECG diagnostic accuracy | 61% ± 12% | 92% ± 6% | 51% increase (p < 0.001) |
| Acute procedural success rate | — | 96.5% | — |
| Major complication rate | — | 1.8% | — |
| Patient education score (0-10) | 4.8 ± 2.1 | 8.2 ± 1.4 | 71% increase (p < 0.001) |
| Anticoagulation non-adherence | 31% | 11% | 65% reduction (p < 0.001) |
| Composite adverse cardiovascular events | 9.6%/year | 6.2%/year | 36% reduction (HR 0.64; 95% CI 0.50-0.82; p < 0.001) |
These findings were not included in the original petition due to the ongoing peer-review process at the time of filing. The manuscript has now been submitted and is under review, and I have included the full manuscript as Exhibit 63. This evidence directly addresses the RFE’s concern regarding documentation of “potential prospective impact” by showing that my model has already produced substantial improvements in a real-world implementation.
A critical element of the proposed endeavor is the strategic alignment with PCORnet, the National Patient-Centered Clinical Research Network. PCORnet is a distributed network of Clinical Research Networks that connects major academic medical centers with community practices across the United States. PCORnet is intended to improve the nation’s capacity to efficiently conduct patient-centered health research, particularly comparative clinical effectiveness research, by providing a large, highly representative network of health data, research expertise, and patient insights.
The institutions identified as key nodes in the proposed Atlanta and Georgia care pathway are active participants in this infrastructure. Emory University is a partner in the OneFlorida+ Clinical Research Network, and Wake Forest University School of Medicine, which maintains a significant presence in Georgia, is a partner in the STAR Clinical Research Network. These networks provide pre-existing, standardized data infrastructure that could support a coordinated, system-level intervention.
I recognize that leveraging PCORnet’s resources requires establishing formal relationships with participating institutions. To this end, I have taken initial steps toward engagement. I have proactively contacted the PCORnet Front Door and will attend an office hours session on March 24, 2026, to explore how to connect with participating PCORnet sites and to better understand the requirements for collaboration. While I have not yet secured formal agreements, this engagement represents the first step toward the type of data infrastructure integration that would strengthen the proposed endeavor. I am prepared to provide documentation of any formal agreements or letters of support as they are secured.
A demonstrable element of the proposed endeavor’s implementation feasibility is my proactive effort to engage with established United States cardiovascular quality infrastructure. Since the original filing, I have taken concrete, documented steps to position this initiative for potential implementation within the U.S. healthcare system by initiating the enrollment process for the American College of Cardiology’s National Cardiovascular Data Registry (NCDR) programs.
Specifically, on December 5, 2025, I formally requested enrollment packages for the AFib Ablation Registry™ through the ACC’s Global Quality program. This registry is a premier platform for tracking procedural outcomes, benchmarking performance against national standards, and driving quality improvement in atrial fibrillation care. The AFib Ablation Registry is the fastest-growing registry within the NCDR and is designed to capture the evolving landscape of AFib ablation, including the use of novel energy sources, procedural outcomes, and follow-up data through one year post-procedure.
My engagement with the ACC registry program has been active and sustained. Following my initial request, the NCDR Customer Support Team acknowledged receipt and forwarded my request to the Account Management Team for further processing. I subsequently followed up on December 16, 2025, to ensure the enrollment process proceeded in a timely manner.
I recognize that enrollment in the AFib Ablation Registry requires participation by a U.S.-based medical facility. My initial request was exploratory, intended to understand the enrollment process and requirements. I am actively exploring opportunities to partner with a U.S. institution that could serve as the enrolling entity for this registry. This registry enrollment initiative demonstrates that my proposed endeavor is not dependent on a single employer, but rather on the ability to establish the data infrastructure necessary for quality measurement and improvement.
These documented registry enrollment activities directly address the RFE’s concerns regarding the feasibility and specificity of my implementation plan. They provide evidence that I have moved beyond conceptual planning and have initiated the operational steps necessary to understand and navigate the U.S. quality infrastructure. When combined with the validated results from prior implementation and the tangible assets I possess, this evidence demonstrates that I am actively working to build the foundation required to execute my proposed endeavor.
PART THREE: DEVELOPMENT OF THE MULTILEVEL MODEL IN TURKEY
The conceptual and operational foundation of the proposed U.S. endeavor is based on a multilevel cardiovascular education and referral model that was previously developed and implemented in Turkey. This model was designed in response to the recognition that effective arrhythmia care is not solely dependent on the availability of advanced electrophysiological procedures, but rather on the coordinated functioning of the entire care pathway, beginning with patient awareness and extending through diagnosis, referral, and definitive treatment.
In this framework, tertiary electrophysiology centers in Turkey functioned as high-level expertise nodes responsible for advanced diagnostic and interventional procedures, including catheter ablation. These centers were supported by regional cardiology hubs that served as intermediate coordination points, facilitating patient evaluation, initiating treatment, and ensuring timely referral to tertiary care when necessary. A critical component of the model was the structured education of physicians across multiple specialties, including cardiologists, internists, family physicians, and general practitioners. This educational component focused on improving arrhythmia recognition, electrocardiographic interpretation, symptom assessment, and appropriate referral timing.
At the community level, the model incorporated targeted patient education initiatives aimed at increasing awareness of arrhythmia-related symptoms, stroke risk, and the importance of early medical evaluation and treatment adherence. This component addressed a key barrier in arrhythmia care, as many patients with intermittent or non-specific symptoms often delay seeking care or present to non-specialized settings without appropriate follow-up.
Importantly, this model was not theoretical but was implemented in a real-world clinical setting and evaluated through a structured interventional study. The results demonstrated significant improvements across multiple domains, including a marked reduction in time to diagnosis, improved efficiency of referral pathways, increased adherence to guideline-directed therapy, and enhanced physician diagnostic accuracy. Most notably, the implementation of this multilevel system was associated with a 36 percent reduction in adverse cardiovascular outcomes, including stroke, heart failure hospitalization, and arrhythmia-related emergency visits.
Demonstrated Capacity for Institutional Collaboration
My prior implementation of this model required extensive collaboration with multiple institutions across Turkey. This work involved coordination with:
This experience demonstrates my ability to establish and maintain the type of multi-institutional collaborations that the proposed U.S. endeavor requires. The same skills—relationship building, program design, and coordination across different levels of care—are transferable to the U.S. healthcare context. While the specific institutions and regulatory frameworks differ, the underlying capability to design, implement, and coordinate a multilevel intervention across multiple sites is directly applicable.
These findings demonstrate that a coordinated, multilevel approach to arrhythmia care can produce meaningful improvements in both clinical outcomes and system efficiency. The model validated in Turkey therefore provides a strong empirical foundation for the proposed implementation in the United States, supporting both its feasibility and its expected impact within a similarly complex healthcare environment.
PART FOUR: PUBLIC HEALTH NEED IN THE UNITED STATES
The public health need for the proposed initiative in the United States is substantial, well-documented, and directly relevant to current national healthcare priorities. Cardiac arrhythmias, particularly atrial fibrillation, represent one of the most prevalent and clinically significant cardiovascular conditions, affecting millions of individuals and contributing to a wide range of serious complications, including stroke, heart failure, recurrent hospitalization, and increased mortality.
However, the significance of this issue extends beyond disease prevalence alone. A considerable portion of the burden associated with arrhythmias arises from systemic inefficiencies in healthcare delivery, particularly in the early stages of the patient pathway. Many patients fail to recognize symptoms such as palpitations, irregular pulse, dizziness, syncope, or unexplained fatigue as indicators of a potentially serious condition requiring medical evaluation. As a result, patients often present late in the disease course, at which point complications may already have developed.
At the same time, frontline physicians—including primary care providers, general practitioners, and non-electrophysiology cardiologists—frequently encounter practical challenges in identifying which patients require further evaluation or specialist referral. Variability in clinical recognition, electrocardiographic interpretation, and familiarity with referral criteria can contribute to delayed diagnosis and inconsistent initiation of guideline-directed therapy. This gap between symptom onset, clinical recognition, and appropriate referral represents a critical point of inefficiency within the healthcare system.
These challenges are further compounded by disparities in access to cardiovascular specialty care. In many regions of the United States, particularly in rural and underserved areas, access to electrophysiology specialists is limited or unevenly distributed. As a result, patients may experience prolonged delays before receiving appropriate evaluation or advanced treatment, even when such care is available elsewhere within the system.
Importantly, these issues do not primarily reflect a lack of clinical capability within the United States healthcare system. Advanced diagnostic and interventional resources are widely available, particularly in major metropolitan centers. Rather, the problem lies in the absence of a structured, coordinated framework that connects existing resources in an efficient and timely manner. Patients are often not guided effectively through the care pathway, and available expertise is not consistently utilized at the appropriate stage of disease progression.
The proposed endeavor directly addresses this structural gap by focusing on early recognition, physician education, and referral coordination. By improving patient awareness, enhancing the diagnostic capabilities of frontline physicians, and establishing structured referral pathways, the initiative aims to reduce delays in care, improve treatment initiation, and ensure more efficient use of existing healthcare resources.
In this context, the proposed project is not limited to improving individual clinical encounters but is designed to enhance the overall performance of the healthcare delivery system. It responds to a clearly identified public health need by targeting the early stages of care, where intervention has the greatest potential to prevent complications, reduce healthcare utilization, and improve long-term outcomes.
PART FIVE: U.S. CARDIOLOGIST SHORTAGE AND WORKFORCE IMPACT
While the proposed endeavor is not predicated solely on the existence of a workforce shortage, current workforce dynamics in the United States provide important context for its significance. Access to cardiovascular care—and particularly to subspecialty services such as electrophysiology—is unevenly distributed across the country. In many regions, especially rural and underserved areas, patients experience delays in accessing specialist evaluation, and referral pathways are often inefficient or inconsistent. These realities increase the importance of early recognition and appropriate triage at the level of frontline providers.
However, workforce shortages alone are not sufficient to establish national importance, as such issues are typically addressed through the labor certification process. The proposed endeavor is therefore not based on the premise of simply adding one additional cardiologist to the workforce. Instead, it addresses a more fundamental issue: how to improve the effectiveness and reach of the existing healthcare workforce through system-level enhancement.
The initiative is designed to strengthen the functional capacity of frontline physicians—including primary care providers, general practitioners, internists, and non-electrophysiology cardiologists—by improving their ability to recognize arrhythmia-related symptoms, interpret common clinical and electrocardiographic findings, and identify patients who require timely referral. By increasing diagnostic accuracy and clinical confidence at these early stages, the model reduces variability in care and enables more consistent application of guideline-directed management.
In practical terms, this approach extends the impact of the existing cardiology workforce without requiring a proportional increase in specialist numbers. Patients can be identified earlier, referred more appropriately, and managed more efficiently, thereby reducing unnecessary delays and improving overall system performance. At the same time, specialist electrophysiology centers can receive more accurately selected patients, improving procedural efficiency and optimizing the use of high-level resources.
This represents a meaningful shift from a workforce-expansion model to a workforce-optimization model. Rather than focusing on increasing the number of specialists, the proposed endeavor enhances how the entire care pathway functions by improving coordination, education, and decision-making across multiple levels of care.
Accordingly, the workforce impact of the proposed endeavor lies not in filling a specific position, but in increasing the effectiveness of the broader healthcare system. By enabling existing providers to function more efficiently and by improving the alignment between patient need and specialist care, the initiative contributes to a more responsive, accessible, and sustainable cardiovascular care system.
PART SIX: NATIONAL HEALTHCARE POLICY ALIGNMENT
The proposed endeavor is closely aligned with major healthcare priorities and policy objectives in the United States, particularly those emphasizing preventive care, early detection of disease, reduction of avoidable complications, and improved access to care across diverse populations. National health strategies consistently highlight the importance of identifying conditions earlier in their course, strengthening patient education, and improving care coordination in order to reduce both clinical burden and healthcare costs. The focus of this initiative—enhancing awareness, diagnostic recognition, and referral efficiency in arrhythmia care—directly supports these objectives.
Cardiovascular disease remains a leading cause of morbidity, mortality, and healthcare expenditure in the United States, and atrial fibrillation plays a central role in this burden due to its association with stroke, heart failure, and recurrent hospitalizations. National guidelines and public health efforts emphasize the importance of early diagnosis, appropriate anticoagulation, and timely intervention as key strategies for improving outcomes. However, achieving these goals in practice depends not only on the availability of treatments, but also on the effectiveness of the systems that guide patients into care at the appropriate time. The proposed endeavor addresses this implementation gap by strengthening the earlier stages of the care pathway, where delays and inefficiencies most commonly occur.
In addition, federal and state-level healthcare initiatives increasingly prioritize care coordination and the integration of public health and clinical systems. Programs designed to improve healthcare delivery in underserved and rural communities emphasize the need to optimize existing resources, enhance provider education, and create structured pathways that connect patients to appropriate levels of care. The proposed model is inherently consistent with these priorities, as it leverages existing Public Health District infrastructure, strengthens the capabilities of frontline providers, and introduces a coordinated referral framework without requiring the development of new facilities.
The alignment of this endeavor with initiatives such as the Georgia Rural Health Transformation Program further underscores its policy relevance. This program focuses on improving access to care, enhancing system efficiency, and addressing disparities in healthcare delivery through coordinated, system-level approaches. The proposed model directly reflects these principles by integrating public health functions with clinical care pathways and by targeting inefficiencies that contribute to delayed diagnosis and treatment.
From a broader perspective, this alignment demonstrates that the proposed endeavor is not an isolated or institution-specific effort, but one that responds to recognized national and regional healthcare priorities. By addressing a documented gap in care delivery and by supporting policy-driven goals related to prevention, access, and coordination, the initiative is positioned to contribute meaningfully to the improvement of healthcare systems beyond a single local context.
PART SEVEN: GOVERNMENT AND INSTITUTIONAL INTEREST
The proposed endeavor aligns with and is supported by broader patterns of government and institutional interest in improving cardiovascular care delivery through coordinated, system-level approaches. Across the United States, federal and state agencies, public health authorities, and major healthcare systems have increasingly emphasized the need to move beyond isolated clinical interventions toward integrated models that improve early detection, care coordination, and access to specialty services.
Government health agencies have consistently identified cardiovascular disease—and particularly preventable complications such as stroke—as a priority area for intervention. This focus has led to sustained efforts aimed at improving early diagnosis, increasing adherence to guideline-directed therapy, and reducing disparities in access to care. Central to these efforts is the recognition that improving outcomes requires not only clinical expertise, but also effective systems that connect patients to appropriate care in a timely and coordinated manner. The proposed endeavor directly addresses this need by strengthening the interface between public health infrastructure and clinical service delivery.
At the state level, initiatives such as the Georgia Rural Health Transformation Program demonstrate a clear institutional commitment to improving care coordination, enhancing access to specialty services, and addressing structural inefficiencies in healthcare delivery. These programs emphasize the optimization of existing resources, the strengthening of provider networks, and the development of scalable solutions that can be implemented across diverse healthcare environments. The proposed model closely reflects these priorities by leveraging Public Health District infrastructure, improving referral pathways, and enhancing the functional capacity of the existing healthcare workforce.
In addition, major healthcare systems and academic institutions have increasingly invested in programs that integrate education, technology, and coordinated care pathways to improve cardiovascular outcomes. These institutional efforts further reinforce the importance of system-level solutions that extend beyond individual clinical encounters. The proposed endeavor complements and strengthens such initiatives by providing a structured framework through which these efforts can be coordinated and expanded.
Importantly, the nature of this interest is not limited to theoretical alignment. The challenges addressed by the proposed model—delayed diagnosis, fragmented referral systems, and underutilization of preventive therapies—are widely recognized by policymakers, healthcare administrators, and clinical leaders. As a result, there is a clear and ongoing institutional demand for solutions that can improve system performance without requiring substantial new infrastructure investment.
By directly responding to these priorities and aligning with existing governmental and institutional objectives, the proposed endeavor demonstrates both practical relevance and broader significance. It represents a solution that is not only consistent with current policy direction, but also capable of contributing to ongoing efforts to improve healthcare delivery at regional and national levels.
PART EIGHT: WHY ATLANTA AND GEORGIA WERE SELECTED AS THE INITIAL U.S. PILOT SITE
The selection of Atlanta and the State of Georgia as the initial implementation site for the proposed endeavor is deliberate, strategic, and grounded in a combination of epidemiological need, healthcare system structure, and policy alignment. This choice reflects not only where the problem is most visible, but also where the proposed solution can be most effectively implemented, evaluated, and scaled.
The southeastern United States carries a disproportionately high burden of cardiovascular disease, including atrial fibrillation, stroke, and heart failure. Georgia is a representative state within this region, where both disease prevalence and healthcare disparities are well documented. According to the Association of Black Cardiologists’ national survey, 45% of adults in the Southern United States remain unaware of the difference between “good” and “bad” cholesterol, and one in four adults travels 10-20 miles to see a heart specialist, with higher rates in Georgia and neighboring states. These findings underscore the critical need for targeted community education and improved access to cardiovascular specialty care in the region, reinforcing the strategic importance of selecting Atlanta and Georgia as the initial implementation site for this initiative.
At the same time, the state exhibits a dual healthcare structure characterized by the coexistence of advanced tertiary medical centers and geographically widespread rural and underserved populations with limited access to subspecialty care. This combination creates a clear and measurable gap between the availability of high-level expertise and the ability of patients to access that expertise in a timely and coordinated manner.
Atlanta, as the largest metropolitan center in Georgia and one of the major healthcare hubs in the southeastern United States, provides an optimal environment for the initial pilot phase. The city hosts multiple high-capacity electrophysiology centers capable of advanced diagnostics and interventional procedures, including catheter ablation. In addition, it contains a dense and diverse healthcare network that includes specialist centers, regional hospitals, and community-based providers. This concentration of resources allows for immediate implementation of a coordinated care model without the need for new infrastructure.
At the same time, Atlanta reflects the structural inefficiencies that the proposed endeavor is designed to address. Despite the presence of advanced medical capabilities, care delivery within the region remains fragmented, and referral pathways are not consistently standardized. Patients frequently experience delays in diagnosis and treatment, and access to appropriate care is influenced by variability in awareness, provider experience, and system coordination. This combination of high capability and operational fragmentation makes Atlanta an ideal setting to demonstrate how a structured, multilevel system can improve healthcare performance.
Equally important is the role of Atlanta as a gateway to broader statewide implementation. The metropolitan region serves as a referral hub for surrounding areas, including many rural and underserved communities across Georgia. By establishing the model in Atlanta, the project creates a central node from which coordinated referral pathways can extend outward, enabling expansion into regions where access to specialty care is more limited.
The selection of Georgia is further supported by its existing public health infrastructure and policy environment. The statewide Public Health District system provides a geographically organized network that can be leveraged for population-level education, screening, and referral coordination. In addition, initiatives such as the Georgia Rural Health Transformation Program demonstrate a clear commitment to improving care coordination, reducing disparities, and optimizing the use of existing healthcare resources. The proposed endeavor aligns directly with these priorities, reinforcing both its feasibility and its relevance within the state.
Taken together, these factors establish Atlanta and Georgia as uniquely suitable for the initial implementation of the proposed model. The region combines high disease burden, existing healthcare capacity, identifiable system-level inefficiencies, and supportive policy frameworks. This convergence enables the project to demonstrate immediate feasibility, generate measurable impact, and establish a scalable model that can be extended to other regions of the United States.
PART NINE: IMPLEMENTATION STRATEGY, INSTITUTIONAL CONTEXT, AND OPERATIONAL DESIGN
The proposed U.S. initiative is intentionally designed to begin with those components of the model that are both immediately feasible within the existing regulatory and institutional framework and capable of generating measurable system-level impact without dependence on initial clinical licensure or affiliation with a single institutional employer. In its initial phase, the endeavor focuses on three interrelated and foundational elements: structured patient education, targeted physician education (through partnership with U.S. institutions), and the development of a standardized referral logic that connects early recognition to advanced electrophysiology care.
This design reflects a central observation underlying the entire proposal: the most critical inefficiencies in arrhythmia care do not arise from a lack of advanced medical capability, but from fragmentation in the earlier stages of the care pathway. As demonstrated in the Atlanta healthcare environment, high-capacity electrophysiology centers—such as Emory University Hospital Midtown and Piedmont Atlanta Hospital—are capable of delivering advanced electrophysiological procedures, including catheter ablation. However, these centers exist within a broader network of hospitals with varying levels of cardiology capability, including specialist electrophysiology centers such as Northside Hospital Atlanta, WellStar Kennestone Regional Medical Center, Emory Decatur Hospital, and Piedmont Fayette Hospital, as well as regional cardiology institutions such as WellStar Douglas Medical Center, Southern Regional Medical Center, Piedmont Henry Hospital, and Piedmont Rockdale Hospital, which provide diagnosis and initial management but lack comprehensive electrophysiology infrastructure.
This distribution creates a structurally inefficient system in which advanced expertise is available but not systematically accessible. Patients frequently experience delayed diagnosis, inconsistent initiation of anticoagulation therapy, and prolonged time to definitive intervention due to the absence of standardized and coordinated referral pathways. Importantly, this inefficiency does not arise from a lack of clinical capability, but from the absence of an integrated system that connects existing resources in a timely and structured manner.
Building upon the Atlanta pilot, the same model is extended to a statewide level across Georgia. The statewide system incorporates all 18 Public Health District Offices—Rome, Dalton, Gainesville, Marietta, Atlanta, Jonesboro, Lawrenceville, Decatur, LaGrange, Dublin, Macon, Augusta, Columbus, Valdosta, Albany, Savannah, Waycross, and Athens—creating a geographically comprehensive population health entry network. This network is integrated with a tiered hospital structure that includes tertiary electrophysiology hubs such as Emory University Hospital Midtown, Piedmont Atlanta Hospital, and Atrium Health Navicent Medical Center, along with specialist centers, regional cardiology institutions, and rural or limited-access facilities.
The statewide model addresses a clearly identifiable structural deficiency: the geographic concentration of electrophysiology expertise combined with the absence of a standardized referral system connecting rural and community-based providers to advanced care centers. By establishing a unified referral architecture, the model ensures early detection, efficient escalation, and equitable access to advanced treatment across both urban and rural populations.
The implementation of the proposed endeavor is intentionally structured as a phased, operationally realistic, and scalable process that prioritizes immediate feasibility while establishing the foundation for long-term system integration. The design reflects a deliberate strategy: to initiate the model through components that can be deployed without dependence on institutional employment, advanced infrastructure, or full clinical integration, while ensuring that each phase directly connects to the broader multilevel system.
The initial phase focuses on patient education, physician education (through partnership with U.S. institutions), and the establishment of referral logic, as these represent the most critical leverage points within the current arrhythmia care pathway. At this stage, the development and dissemination of structured educational materials are implemented through community-oriented and digitally accessible platforms. Patient-facing content is designed to improve recognition of early symptoms—such as palpitations, irregular pulse, dizziness, syncope, and unexplained fatigue—and to emphasize the importance of timely medical evaluation. This component is intended to shift patient entry into the healthcare system toward earlier stages of disease, where intervention is more effective and complications are more preventable.
Concurrently, the model incorporates a structured physician education framework developed in partnership with U.S. academic institutions. This framework targets first-contact providers and non-electrophysiology clinicians, including primary care physicians, internists, general practitioners, and general cardiologists. The educational content focuses on practical clinical decision-making, including early arrhythmia suspicion, electrocardiographic interpretation, identification of high-risk presentations, and appropriate referral timing. By improving diagnostic accuracy and confidence at the frontline level, this phase strengthens the initial gateway into the cardiovascular care system and reduces variability in early-stage management.
In parallel with these educational components, the initiative introduces a standardized referral logic that defines how patients are escalated through the healthcare system once an arrhythmia is suspected or identified. This operational framework is aligned with the existing structure of the Atlanta healthcare network, in which community-level access points connect to regional cardiology centers, which in turn interface with specialist electrophysiology services and tertiary electrophysiology hubs. Rather than creating new referral pathways, this approach formalizes and optimizes existing relationships, ensuring that patients are directed to the appropriate level of care in a timely and consistent manner.
As the model progresses beyond the initial phase, subsequent stages focus on strengthening coordination between these levels, integrating referral pathways more systematically, and expanding the network to include a broader range of institutions across the Atlanta metropolitan area and the State of Georgia. This includes alignment with Public Health District Offices, which function as population-level entry points for screening, education, and referral activation, thereby linking community-based awareness efforts with clinical care delivery.
Importantly, the operational design does not rely on the construction of new facilities or the immediate expansion of the specialist workforce. Instead, it leverages existing infrastructure, enhances communication between providers, and improves the efficiency of resource utilization. This approach allows the initiative to be implemented with relatively modest initial requirements while producing measurable improvements in care coordination and patient flow.
The phased structure of the implementation ensures that each component of the model is both independently functional and cumulatively integrated. Early-stage educational and coordination efforts generate immediate impact, while also establishing the conditions necessary for deeper system integration and geographic expansion. This progression from localized implementation in Atlanta to broader statewide deployment in Georgia reflects a practical and scalable pathway, enabling the model to evolve from a targeted pilot into a comprehensive healthcare delivery framework.
In summary, the implementation strategy is designed to be immediately actionable, operationally efficient, and inherently scalable. By beginning with education and referral coordination, and progressively integrating clinical and public health systems, the proposed endeavor establishes a sustainable model capable of improving arrhythmia care delivery across multiple levels of the United States healthcare system.
PART TEN: IMPLEMENTATION STRATEGY, TIMELINE, AND BUDGET
The implementation of the proposed endeavor is intentionally structured as a phased, operationally realistic, and scalable process that prioritizes immediate feasibility while establishing the foundation for long-term system integration. The design reflects a deliberate strategy: to initiate the model through components that can be deployed without dependence on institutional employment, advanced infrastructure, or full clinical integration, while ensuring that each phase directly connects to the broader multilevel system.
Phase 1 (Months 1-12): Initial Pilot in Atlanta — Foundational Education and Referral Infrastructure
This phase focuses on the development and deployment of patient education and foundational physician education content, as well as the establishment of a functional referral logic within the Atlanta healthcare network. Key activities include:
Partnership Development Activities (Phase 1):
| Activity | Timeline | Status |
| ACC AFib Ablation Registry enrollment exploration | Months 1-12 | Initiated (December 2025) |
| PCORnet engagement and exploration | Months 1-6 | Initiated (March 2026 meeting) |
| Initial outreach to Georgia Public Health District Offices | Months 1-6 | Planned |
| Partnership discussions with U.S. academic institutions | Months 6-12 | In progress |
| Identification of potential simulation system hosting sites | Months 6-12 | Planned |
This phase is expected to produce early measurable outcomes, including improved patient awareness, increased referral appropriateness, and reduced delays in initial evaluation. Simulation-based training is not introduced in this phase, as the initial priority is to strengthen the frontline recognition and referral infrastructure and to establish the partnerships necessary for subsequent phases.
Phase 2 (Months 12-24): Expansion Across the Atlanta Metropolitan Region and Statewide Coordination — Simulation-Based Training Partnership
As referral pathways mature and partnerships with U.S. academic institutions are established, this phase introduces structured simulation-based training programs delivered through partner institutions. Key activities include:
This phase establishes a coordinated metropolitan network with measurable improvements in system efficiency, patient flow, and access to specialist care. The simulation-based training component, delivered through partner institutions, ensures that U.S. physicians are trained by U.S. faculty who have been trained in my methodology.
Phase 3 (Months 24-36): Statewide Expansion Across Georgia — Sustainable Training Infrastructure
Building on the validated Atlanta pilot and the established simulation-based training partnerships, this phase extends the initiative statewide. Key activities include:
This phase establishes a comprehensive, statewide system with measurable population-level improvements in diagnostic timing, treatment adherence, and cardiovascular outcomes.
The proposed endeavor is intentionally designed to minimize reliance on capital-intensive investment. The phased implementation is centered on education, coordination, and system organization rather than infrastructure development. Primary cost components include the development of educational materials, organization of training programs, digital dissemination platforms, and coordination activities required to establish and maintain referral pathways. These costs are modest relative to traditional healthcare expansion models, as the initiative leverages existing institutional capacity rather than requiring new facilities or equipment.
I have submitted a grant application to support this initiative, with a proposed budget that reflects the phased implementation plan. The budget includes funding for program leadership, educational content development, digital platform and dissemination, physician training workshops, community outreach, and monitoring and evaluation activities. The total direct costs requested for the initial budget period (12 months) are $150,000, with funding planned for a three-year project period.
The initial costs of this project will be supported through my personal funds. As demonstrated by the bank statement provided with this response, I have approximately $750,000 in available funds, which ensures that the project can proceed without delay while grant funding is being secured.
PART ELEVEN: IMPLEMENTATION FEASIBILITY
The proposed endeavor is inherently feasible because it is designed to operate within the existing structure of the United States healthcare system, relying on coordination, education, and optimization of current resources rather than the creation of new infrastructure or dependence on a single institutional role. The implementation strategy deliberately begins with components that can be deployed immediately—patient education, physician education content development, and structured referral logic—thereby allowing the initiative to generate measurable impact from its earliest stages without requiring prior employment, facility ownership, or extensive capital investment.
A key factor supporting feasibility is that all critical elements of the proposed model are already present within the Atlanta and Georgia healthcare environment. The system includes:
These existing resources represent an underutilized asset that can be immediately integrated into the proposed model without requiring new organizational structures or capital investment.
The feasibility of the initiative is further reinforced by the fact that the proposed model does not depend on the development of new facilities, acquisition of specialized equipment, or expansion of the specialist workforce. Instead, it improves how existing components interact by introducing:
This approach minimizes logistical barriers and allows implementation to proceed within the constraints of current regulatory and institutional frameworks.
Operational feasibility is also supported by the phased implementation design set forth in Part Ten. The initial phase focuses on patient education and referral coordination, which can be implemented through digital platforms, community engagement, and professional training programs without requiring formal institutional integration. As these components begin to influence patient behavior and physician decision-making, subsequent phases progressively strengthen coordination across healthcare providers and expand the network to additional institutions and regions. This stepwise progression ensures that each phase is both independently functional and cumulatively integrated into a broader system.
Importantly, the proposed endeavor is not hypothetical. Its feasibility is supported by prior real-world implementation of a structurally similar multilevel model in Turkey, which was evaluated through a structured interventional study involving 11 rural healthcare facilities, 524 patients, and 31 rural physicians. The results demonstrated:
These results confirm that the underlying approach—focused on education, coordination, and system integration—is both practical and effective in complex healthcare environments.
From a systems perspective, the initiative aligns with existing healthcare priorities and ongoing efforts to improve care coordination and reduce disparities. The alignment with initiatives such as the Georgia Rural Health Transformation Program and federal priorities emphasizing preventive care, early detection, and reduction of avoidable complications further supports its practical implementation. The presence of aligned policy frameworks and institutional interest reduces barriers to adoption and facilitates integration into the current healthcare landscape.
As detailed in Part Ten, the initiative is designed to minimize reliance on capital-intensive investment. The initial costs will be supported through my personal funds (approximately $750,000 in available funds), with grant funding being pursued for long-term sustainability. This financial structure ensures that the project can proceed without delay while maintaining independence from institutional employment.
PART TWELVE: WHY I AM WELL POSITIONED TO ADVANCE THE PROPOSED ENDEAVOR
I am well positioned to advance the proposed endeavor because my professional background combines clinical expertise in cardiology with demonstrated experience in designing, implementing, and evaluating system-level interventions in arrhythmia care. My work has not been limited to individual patient management; rather, it has focused on improving how patients are identified, evaluated, and guided through the healthcare system, which directly aligns with the objectives of the proposed initiative.
The foundation of this positioning lies in my prior development and real-world implementation of a multilevel arrhythmia care model in Turkey. This model integrated patient education, physician training, and structured referral coordination across multiple levels of care, including community settings, regional cardiology centers, and tertiary electrophysiology units. Importantly, this was not a conceptual framework but an operational system that was implemented and evaluated in a clinical setting. The results demonstrated measurable improvements, including reductions in diagnostic delay, improved referral efficiency, increased adherence to guideline-directed therapy, and a significant reduction in adverse cardiovascular outcomes. These outcomes confirm my ability not only to conceptualize a system-level solution but also to execute it effectively and generate measurable impact.
In addition to clinical and implementation experience, my work reflects a strong understanding of the structural challenges inherent in arrhythmia care delivery, particularly the gap between early symptom recognition and access to advanced electrophysiology services. This insight is critical, as the proposed endeavor is specifically designed to address these early-stage inefficiencies through education and coordination rather than through procedural expansion alone. My prior work demonstrates familiarity with the full continuum of care, from frontline clinical decision-making to advanced intervention, enabling me to design interventions that are both clinically relevant and operationally practical.
I also possess the ability to engage multiple levels of the healthcare system, including patients, frontline physicians, and specialist providers. The proposed model requires coordination across these groups, and my previous experience in developing educational programs and structured referral pathways provides a direct foundation for this type of engagement. This includes the ability to translate clinical knowledge into practical educational content, to identify gaps in physician training, and to design systems that improve communication and coordination between providers.
I hold the title of Professor of Cardiology and am trained as an electrophysiology cardiologist. These credentials are not evidence that I seek a traditional clinical role; rather, they are the foundation of credibility, expertise, and experience that enable me to design, implement, and support the system-level intervention I propose.
My clinical expertise allows me to:
In this endeavor, my clinical identity serves as the platform from which I build a system-level intervention. I am not seeking to use this identity to fill a patient-facing clinical position. I am seeking to use this identity to create a durable, scalable infrastructure that improves arrhythmia care across multiple institutions and populations.
A critical element of my ability to support the physician education component of this endeavor is a tangible asset I possess: a state-of-the-art interventional simulation system specifically designed to train cardiologists and electrophysiologists in advanced, minimally invasive procedures. This system is a physical platform that I own and can deploy immediately upon implementation. It allows for realistic, hands-on simulation of complex procedures, including those utilizing electromagnetic catheter navigation technologies, with which I gained extensive experience during my postdoctoral research and clinical fellowship in Zurich.
I recognize that owning simulation equipment does not, by itself, authorize me to provide medical education in the United States. The U.S. healthcare system has established regulatory frameworks, accreditation requirements, and institutional structures for continuing medical education. My role is not to operate outside these frameworks, but to contribute to them through strategic partnership.
My Contribution to U.S. Physician Education Will Be Structured as Follows:
First, I will develop educational content. My expertise in simulation-based education, developed through my experience in a European Heart Rhythm Association (EHRA) Recognized Training Centre, enables me to create evidence-based curricula, training protocols, and assessment tools. These materials are designed to be adopted and delivered by U.S. institutions.
Second, I will seek partnerships with U.S. academic institutions. Rather than functioning as an independent educator, I will seek to collaborate with U.S. medical schools, teaching hospitals, and simulation centers that possess the legal authority, institutional framework, and accreditation to deliver continuing medical education. These partners would sponsor educational activities, provide necessary liability coverage, and ensure compliance with U.S. regulatory requirements.
I recognize that I have not yet secured formal partnership agreements with U.S. institutions. The phased implementation plan reflects a realistic timeline for developing these relationships, beginning with outreach and exploration in Phase 1 and moving toward formal agreements in Phase 2.
Third, I will implement a train-the-trainer model. Once partnerships are established, I will train U.S. faculty members—who already hold medical licenses, academic appointments, and hospital privileges—in my simulation methodology. These trained U.S. educators will then incorporate my techniques into their existing fellowship and continuing education programs. This creates a sustainable, scalable impact: the U.S. physicians I train become multipliers who can train others, extending the reach of advanced arrhythmia care across multiple institutions and regions.
Fourth, I will provide simulation infrastructure to partner institutions. My simulation system is a physical asset that can be deployed at partner institutions. These institutions would operate the system under their own licenses, accreditations, and institutional policies. This model ensures that all educational activities are conducted within the established U.S. regulatory framework while still leveraging my unique expertise and tangible assets.
Why This Partnership-Based, Train-the-Trainer Model Strengthens My Petition
This approach directly addresses the RFE’s underlying concerns:
Unlike physician education, which requires partnership with U.S. institutions, the patient education component of my endeavor can be implemented independently. I have already developed evidence-based patient education materials that have been published and used in clinical practice. These materials can be adapted for U.S. audiences and disseminated through:
This component does not require U.S. medical licensure, hospital privileges, or institutional sponsorship. It can begin immediately upon approval of this petition and will generate measurable impact in the form of improved patient awareness, earlier care-seeking behavior, and increased treatment adherence.
The RFE noted that I had not provided evidence of progress toward obtaining U.S. medical licensure. Since the original filing, I have taken concrete steps in this direction. In December 2025, I successfully completed the American College of Cardiology’s Certified Cardiovascular Knowledge (CCK) Credential for Physicians Practicing Outside the U.S. This credential, awarded by the ACC, is designed specifically for international cardiologists seeking to demonstrate their clinical knowledge and competence for U.S. practice. It is a rigorous examination that tests knowledge across all domains of cardiovascular medicine, and my successful completion demonstrates that my clinical expertise meets U.S. standards.
However, it is important to emphasize that my proposed endeavor does not require immediate clinical licensure to begin implementation. The patient education component, partnership cultivation, and educational content development can proceed independently of direct patient care. The licensure process is being pursued to enable full integration into the U.S. healthcare system over the long term, but it is not a prerequisite for the initial phases of my endeavor.
My medical school, the University of Health Sciences Gulhane Faculty of Medicine, is listed in the World Directory of Medical Schools and is recognized by the Educational Commission for Foreign Medical Graduates (ECFMG) for graduates from 1981 to present. I have submitted my application for ECFMG Certification and have obtained my Federation of State Medical Boards (FSMB) Federation ID (FID: 308526938), which is the first step toward U.S. medical licensure. These steps demonstrate my commitment to full integration into the U.S. healthcare system over time, while the independent nature of my initial work ensures that the project can proceed without delay.
In summary, I am well positioned to advance the proposed endeavor because:
This combination of proven implementation experience, tangible assets, educational expertise, and demonstrated commitment positions me to successfully advance the proposed endeavor.
PART THIRTEEN: COMPREHENSIVE CITATION ANALYSIS ADDRESSING RFE CONCERNS
The RFE raised specific concerns regarding the citation evidence I submitted in my original petition. Specifically, the RFE noted that “there is no evidence in the record that distinguishes how many of these citations are independent, as opposed to self-citations” and that I did not offer “comparative statistics indicating how often other individuals in the field are cited.” The RFE further stated that without this evidence, it cannot be proven that my citation record is indicative of a record of success or otherwise demonstrates I am well positioned to advance my proposed endeavor.
In response to these concerns, I have conducted a comprehensive, citation-by-citation analysis of all citations to my publications. This analysis was performed using a conservative verification approach that included: (i) cross-matching each citation title against my own publication list to identify direct self-citations; (ii) reviewing author information for each citing publication to identify citations from former co-authors (dependent citations); and (iii) categorizing the remaining citations as independent. This analysis is presented in detail below.
My publications have received substantial recognition across multiple internationally recognized bibliometric databases. The table below summarizes the citation metrics:
| Database | Total Citations | H-
Index |
Independent Citations (Excluding Self-Citations) | H-Index (Excluding Self-Citations) | Citations from Independent Authors (Excluding Self-Citations and Dependent Authors) | H-Index (Excluding Self-Citations and Dependent Authors) |
| Google Scholar | 395 | 11 | 385 (97.5%) | 11 | 379 (90.1%) | 11 |
| Scopus | 207 | 8 | 197 (97.1%) | 8 | 194 (93.7%) | 8 |
| Web of Science | 196 | 8 | 186 (97.5%) | 8 | 183 (95.4%) | 8 |
| ResearchGate | 269 | 8 | — | — | — | — |
The RFE expressed concern that I had not distinguished self-citations from independent citations. I have conducted a thorough analysis identifying all self-citations in my publication record. A self-citation is defined as a citation where I am listed as a co-author on the citing publication.
Through systematic review of each citation listed in my Google Scholar profile, I identified a total of 10 self-citations among the 395 total citations. This corresponds to a self-citation rate of approximately 2.5%. In bibliometric terms, a self-citation rate below 10-15% is generally considered low in medical research fields. My substantially lower rate of 2.5% is therefore exceptional and demonstrates that the vast majority of citations to my work originate from independent researchers.
As demonstrated in the summary table, even after excluding all self-citations, my citation counts and h-index remain virtually unchanged: 385 citations (97.5% of total) and an h-index of 11 in Google Scholar; 197 citations (97.1% of total) and an h-index of 8 in Scopus; and 186 citations (97.5% of total) and an h-index of 8 in Web of Science.
To further address the RFE’s concerns regarding the independence of citations, I also conducted an analysis of citations from former co-authors (dependent citations). A dependent citation is defined as a citation where the citing publication includes one or more authors who have previously co-authored with me, but where I am not listed as a co-author on the citing publication. This analysis ensures that the citations I claim as independent truly reflect recognition by researchers outside my immediate collaboration network.
I identified a total of 4 dependent author citations in my publication record. Even after excluding both self-citations and dependent author citations, my citation metrics remain exceptionally strong. In Google Scholar, 379 citations (90.1% of total) remain from truly independent authors, with an unchanged h-index of 11. In Scopus, 194 citations (93.7% of total) remain from independent authors, with an unchanged h-index of 8. In Web of Science, 183 citations (95.4% of total) remain from independent authors, with an unchanged h-index of 8.
The RFE noted that I did not offer “comparative statistics indicating how often other individuals in the field are cited.” To address this concern, I have analyzed the citation performance of my publications relative to field norms using the Author Impact Beamplot provided by Web of Science.
As illustrated in the beamplot (Exhibit 75), my publications fall within citation percentiles above the median level (>75%), indicating that my work performs better in terms of citations than the majority of comparable publications within the same research categories and publication years. Several of my publications reach even higher citation percentiles, demonstrating particularly strong citation performance relative to similar publications.
This comparative analysis demonstrates that my citation impact is not merely a reflection of general citation patterns in the field, but rather indicates that my work has achieved recognition that exceeds the average level for comparable publications.
My ResearchGate profile provides additional evidence of scholarly impact. As shown in Exhibit 74, my research has received 269 citations on ResearchGate, with an h-index of 8 and a Research Interest Score of 155.2. Notably, ResearchGate analytics indicate that my Research Interest Score is higher than approximately 70% of all ResearchGate members, placing my research engagement above the majority of researchers represented on the platform. Moreover, the platform’s score breakdown demonstrates that approximately 82.47% of my Research Interest Score is derived directly from citations, indicating that the majority of engagement with my work arises from formal scholarly referencing rather than passive interactions such as views or downloads.
The comprehensive citation analysis presented above directly addresses the RFE’s concerns and demonstrates that: (1) my self-citation rate is exceptionally low at 2.5%, with more than 97% of all citations originating from independent researchers; (2) even after excluding both self-citations and dependent author citations, more than 90% of citations remain from truly independent authors; (3) my h-index remains unchanged across all databases even after excluding self-citations and dependent author citations; (4) comparative analysis shows that my publications perform better than the majority of comparable publications in the field (>75th percentile); and (5) ResearchGate metrics show that my research interest score exceeds approximately 70% of all ResearchGate members, with over 82% of that score derived from citations.
This evidence collectively demonstrates that my research has achieved meaningful scholarly influence and recognition within the global scientific community, and that this influence is driven by independent researchers rather than self-referencing or close collaboration networks. This record of scholarly impact directly supports my ability to advance the proposed endeavor.
PART FOURTEEN: EXPECTED OUTCOMES AND MEASURABLE IMPACT
The expected outcomes of the proposed endeavor are defined in measurable, evidence-based terms and are directly grounded in both prior implementation results and established clinical and health system data. The initiative is designed to produce quantifiable improvements across the full arrhythmia care pathway, including patient behavior, physician performance, referral efficiency, clinical outcomes, and overall healthcare system utilization.
At the patient level, the most immediate and measurable impact is expected to be a substantial reduction in diagnostic delay. In prior implementation of the same multilevel model, the average time from symptom onset to confirmed diagnosis decreased from 14.5 weeks to 5.2 weeks, representing a 64 percent reduction. This improvement is directly attributable to increased patient awareness and earlier presentation for medical evaluation. When applied to the United States context, where delays in arrhythmia diagnosis remain common, a comparable reduction would result in significantly earlier initiation of appropriate therapy and a measurable decrease in preventable complications during the diagnostic period.
A second major outcome is the improvement in adherence to guideline-directed therapy, particularly anticoagulation in patients with atrial fibrillation. In prior implementation, appropriate anticoagulation use increased from 42 percent to 79 percent. This change represents a near doubling of treatment adherence and is associated with a substantial reduction in stroke risk. Given that atrial fibrillation-related strokes are largely preventable, this improvement alone is expected to produce a measurable reduction in both morbidity and mortality, as well as a significant decrease in high-cost acute and long-term care utilization.
The model also produces measurable improvements in referral efficiency and access to advanced care. In prior implementation, the time to catheter ablation decreased from 11.3 months to 4.1 months, representing a 64 percent reduction in referral delay. Earlier access to definitive treatment is associated with improved procedural outcomes, reduced recurrence of arrhythmia, and decreased long-term healthcare utilization. In the United States setting, where delays in referral to electrophysiology services are frequently observed, this improvement represents a critical system-level gain.
At the level of clinical outcomes, the integrated model has demonstrated a 36 percent reduction in major adverse cardiovascular events, including cardiovascular death, stroke, heart failure hospitalization, and arrhythmia-related emergency visits. This magnitude of risk reduction represents a clinically meaningful improvement in patient outcomes and serves as a direct indicator of the effectiveness of the model. When applied at a population level, even conservative estimates suggest that a substantial number of serious adverse events can be prevented annually.
In addition to patient-level outcomes, the initiative is expected to produce measurable improvements in physician performance. Prior implementation demonstrated an increase in diagnostic accuracy from 61 percent to 92 percent and a significant improvement in physician confidence in arrhythmia management. These changes reduce variability in care, improve early-stage clinical decision-making, and enhance the efficiency of patient triage. As a result, patients are more likely to be directed to the appropriate level of care at the appropriate time, reducing both under-referral and unnecessary specialist utilization.
At the system level, these improvements translate into enhanced efficiency and optimized use of existing healthcare resources. Earlier diagnosis, improved treatment adherence, and more efficient referral pathways reduce unnecessary hospitalizations, emergency department visits, and redundant diagnostic testing. This results in a measurable decrease in overall healthcare utilization and associated costs.
The economic impact of these outcomes is substantial. Reduction in stroke incidence alone represents a significant cost saving, as the acute cost of stroke in the United States exceeds $40,000 per event, with lifetime costs reaching up to $150,000. Similarly, reductions in heart failure hospitalizations and emergency visits produce additional savings, given the high cost of cardiovascular admissions. Earlier intervention, including catheter ablation, further reduces long-term costs by decreasing recurrence and the need for repeated care.
PART FIFTEEN: ECONOMIC AND HEALTHCARE COST IMPACT ANALYSIS
The proposed endeavor is expected to generate substantial and measurable economic benefits by addressing key cost drivers in the management of cardiac arrhythmias, particularly atrial fibrillation. The economic impact of the model is not theoretical; it is directly linked to improvements in early diagnosis, increased adherence to guideline-directed therapy, reduction in preventable complications, and more efficient utilization of existing healthcare resources. These effects collectively translate into a clear and quantifiable reduction in healthcare expenditures.
Atrial fibrillation is associated with some of the highest-cost complications in cardiovascular medicine, most notably ischemic stroke. In the United States, the direct cost of an acute stroke event exceeds approximately $40,000, while total lifetime costs—including rehabilitation, long-term care, and indirect costs—range from $90,000 to $150,000 per patient. Because a significant proportion of atrial fibrillation-related strokes are preventable through appropriate anticoagulation, improvements in treatment adherence produce immediate and substantial economic benefit. In prior implementation of the multilevel model, anticoagulation utilization increased from 42 percent to 79 percent, representing a near doubling of appropriate therapy. When applied to a population-level context such as Georgia, even conservative projections suggest that preventing 100 to 200 strokes annually would result in $4 million to $8 million in direct acute care savings, with substantially greater long-term economic impact.
In addition to stroke prevention, the model significantly reduces hospitalization burden, which is a major contributor to healthcare expenditure. Cardiovascular hospitalizations—including those related to heart failure and arrhythmia complications—typically cost between $15,000 and $25,000 per admission in the United States. The demonstrated 36 percent reduction in major adverse cardiovascular events, including hospitalizations and emergency visits, directly translates into a substantial decrease in these costs. Given the frequency and recurrence of such events in patients with untreated or poorly managed arrhythmias, even modest reductions produce a significant cumulative economic impact.
The model also improves the timing and efficiency of advanced interventions, particularly catheter ablation. In prior implementation, referral delays were reduced by 64 percent, allowing patients to undergo definitive treatment at earlier stages of disease. Economic analyses in the United States have shown that early rhythm control strategies, including catheter ablation, result in net savings of approximately $8,000 to $15,000 per patient over several years by reducing recurrence, hospitalizations, and long-term medication use. By accelerating access to these interventions, the proposed model shifts care toward a more cost-effective trajectory, reducing both short-term and long-term expenditures.
Another important source of economic benefit arises from the reduction in diagnostic inefficiency. Delayed or uncertain diagnosis often leads to repeated outpatient visits, unnecessary testing, and avoidable emergency presentations. By reducing diagnostic delay by over 60 percent, the model minimizes redundant healthcare utilization and streamlines the patient pathway, resulting in additional cost savings.
Beyond direct patient-level effects, the proposed endeavor improves system-level efficiency by optimizing the use of existing healthcare infrastructure. The model does not require new facilities, equipment, or workforce expansion. Instead, it enhances the performance of the current system by improving communication between providers, standardizing referral pathways, and increasing diagnostic accuracy. This reduces inappropriate referrals, prevents overutilization of tertiary care, and ensures that high-cost resources are used more effectively.
The combined economic effect of these mechanisms is cumulative and self-reinforcing. Reduction in stroke incidence decreases long-term disability costs, fewer hospitalizations reduce immediate expenditures, earlier intervention lowers recurrence and chronic care costs, and improved system efficiency reduces waste. Together, these factors produce a favorable cost-benefit profile in which relatively modest implementation costs yield disproportionately large savings.
Importantly, these economic benefits are scalable. While initial implementation in the Atlanta metropolitan region is expected to generate significant localized savings, expansion across the State of Georgia would amplify these effects at a population level, resulting in multi-million dollar annual reductions in healthcare expenditure. Further replication in other regions of the United States would extend this impact nationally.
PART SIXTEEN: PROSPECTIVE NATIONAL IMPACT AND EXPANSION PLAN
The proposed endeavor is designed with scalability and transferability as core structural features, enabling its impact to extend beyond a single metropolitan region and contribute meaningfully to the performance of the United States healthcare system at a national level. While the initial implementation is focused on the Atlanta metropolitan area and subsequent expansion across the State of Georgia, the model itself is not geographically limited. Rather, it represents a standardized, adaptable framework that can be applied to multiple healthcare environments characterized by similar patterns of fragmentation, delayed diagnosis, and uneven access to specialty care.
The underlying challenges addressed by the initiative—inefficient early-stage recognition of arrhythmias, variability in frontline clinical decision-making, and lack of structured referral pathways—are not unique to Georgia. These issues are widely recognized across the United States, particularly in regions where advanced cardiovascular services are concentrated in urban centers while surrounding populations experience limited access. As a result, the structural gap between available expertise and timely patient access represents a national healthcare delivery problem.
The proposed model directly targets this gap by improving the earliest and most influential stages of the care pathway. By enhancing patient awareness, strengthening physician diagnostic capability, and introducing standardized referral logic, the initiative creates a system in which patients are identified earlier, referred more efficiently, and treated more appropriately. These improvements are inherently reproducible because they rely on coordination and education rather than localized infrastructure or institution-specific resources.
From a systems perspective, the model is compatible with the diverse organizational structures that exist across the United States healthcare landscape. Whether implemented within integrated health systems, community hospital networks, or mixed public-private environments, the core components—education, coordination, and referral standardization—can be adapted without requiring structural reconfiguration of the system. This flexibility supports broad applicability and facilitates adoption across different regions.
National Scope Expansion Plan
The expansion of the proposed endeavor from an initial Atlanta-based pilot to a broader national framework is designed as a structured, phased, and evidence-driven process. The first stage focuses on consolidating and validating the model within the Atlanta healthcare system. During this phase, the integration of patient education, physician training (through partnership with U.S. institutions), and standardized referral pathways is refined across a network of institutions, including tertiary electrophysiology centers, specialist hospitals, regional cardiology facilities, and community-level providers. Public Health District Offices are incorporated as population-level entry points, enabling structured screening, education, and referral activation.
The second stage extends the model across the State of Georgia. Building on the operational experience gained in Atlanta, the initiative is expanded to incorporate additional Public Health Districts, regional hospitals, and rural healthcare facilities. This phase emphasizes geographic coverage and equitable access, ensuring that patients in both urban and underserved areas are connected to appropriate levels of care through a standardized referral architecture.
Following successful statewide implementation, the third stage focuses on replication in other regions of the United States. The selection of new regions is guided by factors such as cardiovascular disease burden, distribution of healthcare resources, presence of rural or underserved populations, and existing public health infrastructure. The model is designed to be adaptable to different healthcare systems, allowing for customization of referral pathways and institutional participation while maintaining the core structure of education, coordination, and multilevel care integration.
A critical component of the national expansion strategy is the standardization of the model’s core elements. Educational materials, physician training frameworks, and referral protocols are developed in a modular format, enabling consistent implementation across multiple sites while allowing for local adaptation. This standardization ensures that the quality and effectiveness of the intervention are maintained as the model is scaled.
PART SEVENTEEN: CLINICAL LICENSURE INDEPENDENCE STATEMENT
The proposed endeavor is intentionally designed so that its initial implementation and measurable impact do not depend on immediate clinical licensure in the United States or on functioning in a traditional patient-facing physician role. The core components of the initiative—patient education, physician education content development, and structured referral coordination—fall within the domains of public health intervention, medical education, and healthcare system organization, all of which can be initiated and advanced independently of direct clinical practice.
In its early phases, the project focuses on improving awareness, recognition, and coordination within the existing healthcare framework rather than delivering hands-on clinical care. Patient education activities involve the development and dissemination of informational materials and outreach programs aimed at improving recognition of arrhythmia-related symptoms and encouraging timely medical evaluation. These activities are educational and organizational in nature and do not require independent clinical licensure.
Physician education content development involves creating curricula, training protocols, and assessment tools. The delivery of this content will be conducted through partnership with U.S. academic institutions that possess the legal authority, accreditation, and infrastructure to deliver continuing medical education. I will not function as an independent educator; rather, I will support U.S. institutions in enhancing their existing training programs.
Similarly, the establishment of a standardized referral logic represents a system-level coordination effort rather than a clinical act. The initiative defines and facilitates how patients move through existing healthcare structures—from community-level access points to regional cardiology centers and tertiary electrophysiology hubs—without directly providing medical diagnosis or treatment. This function enhances communication and efficiency within the system but does not involve activities that are restricted to licensed clinical practice.
As the project progresses, the model is designed to integrate with licensed healthcare providers and established institutions, ensuring that all clinical decision-making and patient care are conducted by appropriately credentialed professionals within the United States. The role of the proposed endeavor remains centered on system design, coordination, and education, complementing rather than replacing licensed clinical practice.
Importantly, the independence of the initiative from immediate clinical licensure supports both its feasibility and its scalability. Because the foundational components can be implemented without regulatory delay or institutional dependency, the project can begin generating measurable impact at an early stage. At the same time, its structure allows for seamless integration into the licensed healthcare environment as the model expands.
PART EIGHTEEN: WHY THE PROPOSED ENDEAVOR IS INDEPENDENT OF THE LABOR CERTIFICATION PROCESS
The proposed endeavor is fundamentally independent of the labor certification (PERM) process because it does not involve filling a specific job vacancy, competing for a defined employment position, or displacing a U.S. worker within a particular labor market. Rather, it is a system-level initiative designed to improve healthcare delivery through education, coordination, and the optimization of existing resources across multiple institutions and settings.
Unlike a traditional employment-based role, the proposed work is not tied to a single employer, job description, or geographic location. It is structured as a multilevel framework that operates across public health infrastructure, community-based care, regional cardiology services, and tertiary electrophysiology centers. Its implementation involves the development of educational programs, the establishment of standardized referral pathways, and the coordination of care across different levels of the healthcare system. These activities do not correspond to a defined position that could be offered to or filled by a U.S. worker through the labor certification process.
Furthermore, the initiative does not seek to replace or substitute for existing healthcare professionals. On the contrary, it enhances the effectiveness of the current workforce by improving physician knowledge, strengthening early-stage clinical decision-making, and facilitating more efficient referral to appropriate levels of care. The model supports and augments the roles of U.S. healthcare providers rather than competing with them, thereby functioning as a complementary system-level intervention rather than an individual employment function.
The independence of the endeavor is also reflected in its method of implementation. The initial phases—focused on patient education, physician education content development, and referral coordination—can be conducted through professional collaboration, public health engagement, and educational outreach without requiring formal employment within a specific institution. As the model expands, it integrates with multiple healthcare entities simultaneously, further demonstrating that it is not confined to a single employer-employee relationship.
Additionally, the value of the proposed endeavor lies in its ability to improve system performance at scale, rather than in the performance of duties within a particular job role. Its impact is measured by improvements in diagnostic timing, referral efficiency, treatment initiation, and overall healthcare utilization across a population, not by the fulfillment of responsibilities associated with a specific position. This distinguishes it from roles that are appropriately evaluated through the labor certification process, which is designed to assess the availability of U.S. workers for defined employment opportunities.
The labor certification process (PERM) is designed to test the labor market for a specific position with a specific employer at a specific location. It asks whether there are U.S. workers willing and able to fill that position. My proposed endeavor does not correspond to any such position. There is no job description that could capture the scope of this initiative. There is no single employer that could sponsor this work because it spans public health districts, academic medical centers, community hospitals, and professional organizations. There is no labor market test that could assess the availability of U.S. workers for a position that does not exist.
The PERM process is designed to protect U.S. workers from displacement by foreign workers. My proposed endeavor does not displace any U.S. worker because it does not fill any existing position. Instead, it enhances the effectiveness of the existing U.S. healthcare workforce. The physician education content I develop will help U.S. educators train U.S. physicians, making them more effective. The referral coordination component will allow U.S. specialists to focus their expertise on patients who most need it. The patient education component will increase appropriate care-seeking behavior, benefiting the entire healthcare system.
PART NINETEEN: LEGAL RESPONSE UNDER THE DHANASAR FRAMEWORK
The proposed endeavor satisfies all three prongs of the framework established in Matter of Dhanasar, 26 I&N Dec. 884 (AAO 2016), and therefore warrants a favorable exercise of discretion for a National Interest Waiver. The record demonstrates that the endeavor has substantial merit and national importance, that I am well positioned to advance it, and that, on balance, it would be beneficial to the United States to waive the job offer and labor certification requirements.
With respect to the first prong, the proposed endeavor possesses clear and substantial merit in the field of healthcare delivery and public health. It is directed toward improving the recognition, referral, and management of cardiac arrhythmias, particularly atrial fibrillation, a condition that is strongly associated with stroke, heart failure, hospitalization, and mortality. The initiative addresses a well-documented structural inefficiency in the healthcare system—namely, the gap between early symptom recognition, frontline clinical evaluation, and timely access to specialized care. By focusing on patient education, physician training (through partnership with U.S. institutions), and referral coordination, the endeavor targets the stages of care where intervention has the greatest potential to prevent complications and improve outcomes. The substantial merit of the endeavor is further supported by prior implementation of a structurally similar model, which demonstrated measurable improvements in diagnostic timing, treatment adherence, referral efficiency, and a significant reduction in adverse cardiovascular events.
The proposed endeavor also has national importance. The challenges it addresses—delayed diagnosis, fragmented referral pathways, variability in clinical recognition, and disparities in access to specialty care—are not limited to a single region but are widely recognized across the United States healthcare system. The model is specifically designed to improve system performance through coordination and education, rather than through localized or institution-specific interventions. Its initial implementation in Atlanta and expansion across Georgia provide a practical demonstration of feasibility and scalability, while its structure allows for replication in other regions with similar healthcare delivery characteristics. Additionally, the endeavor aligns with national healthcare priorities, including preventive care, reduction of avoidable complications, improvement of care coordination, and optimization of existing resources. These factors collectively establish that the impact of the proposed work extends beyond a single employer or geographic area and is relevant at a national level.
With respect to the second prong, I am well positioned to advance the proposed endeavor. My background includes clinical expertise in cardiology as well as direct experience in designing, implementing, and evaluating a multilevel arrhythmia care model in a real-world setting. This prior work demonstrated measurable and statistically significant improvements in key clinical and operational outcomes, including reductions in diagnostic delay, increased adherence to guideline-directed therapy, improved physician diagnostic accuracy, and a 36 percent reduction in major adverse cardiovascular events. These results provide concrete evidence of my ability to translate a conceptual framework into an operational system and to generate measurable impact. In addition, my experience in physician education, patient awareness initiatives, and system-level coordination directly aligns with the core components of the proposed endeavor. My proactive engagement with PCORnet and my focus on leveraging its infrastructure—including the participation of Emory University in the OneFlorida+ Clinical Research Network and Wake Forest University School of Medicine in the STAR Clinical Research Network—demonstrate a clear strategy for operationalizing the model within the United States healthcare system. My comprehensive citation analysis demonstrates that my scholarly work has achieved sustained independent recognition, with more than 97% of citations originating from independent researchers and my h-index remaining unchanged even after excluding self-citations and dependent author citations. This combination of clinical knowledge, implementation experience, strategic engagement with national research infrastructure, and demonstrated scholarly impact positions me to effectively develop, expand, and sustain the initiative.
With respect to the third prong, it would be beneficial to the United States to waive the requirements of a job offer and labor certification. As previously explained, the proposed endeavor is not tied to a specific employer, position, or labor market test. Its implementation depends on the ability to operate across multiple institutions, engage with public health systems, and coordinate care at a system-wide level. Requiring a traditional job offer would constrain the scope of the initiative and limit its ability to achieve its intended impact. Moreover, the nature of the work—focused on education, coordination, and system optimization—does not correspond to a discrete position that could be filled through the labor certification process. The endeavor enhances, rather than competes with, the existing healthcare workforce, improving the efficiency and effectiveness of care delivery without displacing U.S. workers. The national interest in realizing the substantial benefits demonstrated in prior implementation outweighs the interests protected by the labor certification process, particularly given that the PERM process is not designed for and cannot accommodate system-level initiatives of this nature.
In balancing the factors set forth in Dhanasar, the evidence demonstrates that the proposed endeavor offers substantial public health and economic benefits, that I have the experience and capability to advance it, and that the waiver of a job offer and labor certification would facilitate, rather than hinder, its implementation. Accordingly, the record supports a favorable determination under all three prongs of the Dhanasar framework.
PART TWENTY: CONCLUSION
In conclusion, the evidence presented in this response demonstrates that the proposed endeavor is a structured, evidence-based, and scalable system-level intervention designed to address a clearly identified and well-documented gap in the delivery of arrhythmia care within the United States healthcare system. The initiative is not a traditional clinical role, but a coordinated framework that improves early symptom recognition, enhances physician diagnostic capability (through partnership with U.S. institutions), and establishes efficient referral pathways to advanced electrophysiology care.
The project is grounded in prior real-world implementation of a multilevel model that has already demonstrated measurable improvements in diagnostic timing, referral efficiency, adherence to guideline-directed therapy, and a significant reduction in adverse cardiovascular outcomes. These results provide a validated foundation for the proposed U.S. implementation and confirm that the model is both feasible and capable of producing meaningful clinical and system-level impact.
The selection of Atlanta and the State of Georgia as the initial implementation site is strategically justified by the combination of high cardiovascular disease burden, the coexistence of advanced tertiary care centers and underserved populations, and the presence of existing public health infrastructure that supports coordinated care delivery. This environment allows for immediate implementation and provides a clear pathway for statewide and national expansion. The operational and data foundation for this initiative will be further strengthened through collaboration with PCORnet, leveraging the participation of Emory University in the OneFlorida+ Clinical Research Network and Wake Forest University School of Medicine in the STAR Clinical Research Network to provide the pre-existing data infrastructure and collaborative expertise essential for implementation.
The proposed endeavor produces measurable benefits at multiple levels, including earlier diagnosis, improved treatment initiation, reduced delays in advanced intervention, enhanced physician performance, and more efficient utilization of healthcare resources. These improvements translate into significant reductions in preventable complications such as stroke, decreased hospitalizations and emergency care utilization, and substantial economic savings. Importantly, these outcomes are achieved without requiring new infrastructure, making the model both cost-effective and scalable.
Furthermore, the initiative is independent of a specific employer, clinical licensure at the initial stage, and the labor certification process, as it operates through education, coordination, and system-level optimization rather than through a defined employment role. Its impact is therefore broader than that of a single clinical position and extends across multiple institutions and regions.
My comprehensive citation analysis demonstrates that my scholarly work has achieved sustained independent recognition, with a self-citation rate of only 2.5%, more than 97% of citations originating from independent researchers, and my h-index remaining unchanged even after excluding self-citations and dependent author citations. This record of scholarly impact further supports my ability to advance the proposed endeavor.
Taken together, the record establishes that the proposed endeavor has substantial merit, clear national importance, and a demonstrated capacity for implementation and expansion. It represents a practical and effective solution to a recognized healthcare delivery problem, with the potential to improve patient outcomes, enhance system efficiency, and reduce healthcare costs at a regional and national level.
For these reasons, I respectfully request that the evidence be considered in its entirety and that a favorable determination be made.
Respectfully submitted,
March 23, 2026
Evan John